Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
115.80
-1.70 (-1.45%)
At close: Apr 24, 2025
-40.40%
Market Cap 26.75B
Revenue (ttm) 11.58B
Net Income (ttm) 570.05M
Shares Out 231.00M
EPS (ttm) 2.47
PE Ratio 46.93
Forward PE n/a
Dividend 2.00 (1.73%)
Ex-Dividend Date Oct 28, 2024
Volume 55,619
Average Volume 89,119
Open n/a
Previous Close 117.50
Day's Range 115.00 - 118.90
52-Week Range 104.80 - 206.00
Beta -0.34
RSI 33.01
Earnings Date Apr 30, 2025

About Beacon Pharmaceuticals

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories that include oncology, hematology, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointesti... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 4,162
Stock Exchange Dhaka Stock Exchange
Ticker Symbol BEACONPHAR
Full Company Profile

Financial Performance

In 2024, Beacon Pharmaceuticals's revenue was 10.70 billion, an increase of 25.76% compared to the previous year's 8.51 billion. Earnings were 521.01 million, an increase of 2.19%.

Financial Statements

News

There is no news available yet.